SMTI: Sanara MedTech Company Value to Net Income

Corporate emblem and logo of Sanara MedTech, Inc. (SMTI)

The market for biologics for tissue regeneration and post-surgical healing is growing rapidly. The market dynamics of Sanara MedTech Inc. (SMTI) reflected in the price action shows a value of -99.10. The business relies on absolute crisis resilience, as post-operative care is always vital. Efficiency is achieved by outsourcing drug manufacturing and testing to third-party contractors, as well as optimizing global supply chains to clinics.

Sanara (SMTI) Price to Earnings Ratio: for the period 07/04/2022 - 11/15/2026

Analytical breakdowns for Sanara MedTech Inc.

- price and consensus price forecast:
Stock Price Sanara MedTech|SMTI - Consensus Target
- market capitalization information:
Market Value Sanara|SMTI - Total Company Value
- balance sheet net asset value indicators:
Net Assets per Share Sanara MedTech|SMTI - Company Book Value|Market Capitalization to Book Value Ratio sanaramedtech.com|SMTI - Company Total Assets
- company liabilities and liquidity data:
Total Debt to Capital Coefficient Sanara MedTech Inc.|SMTI - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio sanaramedtech.com|SMTI - Company Debts|Debts to Net Assets Sanara MedTech, Inc.|SMTI - Company Long-Term Debts|Company Short-Term Debts Sanara MedTech|Immediate Liquidity Ratio sanaramedtech.com
- earnings and market multiples details:
SMTI - Net Profit|Projected Future Earnings Sanara MedTech Inc.|SMTI - Price to Earnings Ratio|Future Price to Earnings Multiple Sanara MedTech Inc.|SMTI - PEG Multiple|EV/EBITDA Multiple Sanara MedTech Inc.|SMTI - Operating profit before deduction of amortization|Earnings per share for the trailing year Sanara MedTech|SMTI - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months sanaramedtech.com|SMTI - Earnings growth in current year|Expected net earnings per share growth next year Sanara MedTech Inc.
- sales volume and revenue indicators:
SMTI - Revenue and Sales Volume|Company Revenue Forecast Sanara MedTech|SMTI - Market Cap to Revenue|Price to Expected Revenue Ratio Sanara MedTech, Inc.|SMTI - Sales Growth YoY (TTM)
Comprehensive company analysis:Sanara MedTech Inc.
Manufactured product of sanaramedtech.com

Professional managers utilize fundamental filters to determine the fair value of assets. The price-to-earnings ratio measures the cost of one dollar of earnings, reflecting market expectations for future growth. For Sanara MedTech Inc. (SMTI), steady demand for surgical materials guarantees a consistent profit stream, smoothing valuation volatility. Analyzing the current P/E multiple helps distinguish temporary market fluctuations from a genuine shift in the business cycle.

Key competitors

P/E Multiple Krystal Corp|Price to Earnings Ratio APGE (Apogee Pharma)|ARQT (Arcutis Corp) - Company Value to Net Income|Price to Earnings Ratio vcel.com VCEL|Business Payback Period orukatx.com (ORKA)|DBVT - Price to Earnings Ratio|SLSN - P/E Multiple|DERM: P/E Multiple|FBRX - Business Payback Period|Price to Earnings Ratio Empro Group|Price to Earnings Multiple SLGL (sol-gel.com)|P/E Multiple AXIL|Price to Earnings Ratio Medicus Pharma MDCX|P/E Multiple VRCA (Verrica Pharmaceuticals Inc.)|hoththerapeutics.com (HOTH) - Market Cap to Earnings|BFRI - Price to Earnings Ratio|VYNE (vynetherapeutics.com) - Price to Earnings Multiple|sonomapharma.com (SNOA) - Price to Earnings Ratio|QNRX - Business Payback Period|Price to Earnings Ratio Azitra Corp|P/E Multiple Dermata Therapeutics|P/E Multiple ELAB|Price to Earnings Ratio Revance Therapeutics RVNC